CClinicalTrials.gg
CompletedNCT01500174Updated Sep 5, 2012

Ultraviolet-C Effectiveness in the Management of Pressure Ulcers in People With Spinal Cord Injury

An interventional study of ultraviolet therapy UV254 and Placebo ultraviolet therapy UV254 in Pressure Ulcer, sponsored by Toronto Rehabilitation Institute. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-09-05.

Sponsored by Toronto Rehabilitation Institute · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of the study is to examine the effectiveness of Ultraviolet-C (UVC) for healing pressure ulcers in people with spinal cord injury. UVC is a form of radiation similar to sunlight but it is normally absorbed in the earth's atmosphere. Participants will be assigned by chance to receive placebo-UVC or real UVC treatment, in addition to receiving wound care according to best practice guidelines. The hypothesis is that UVC-treated wounds will heal at a faster rate than wounds receiving placebo treatment.

Given that pressure ulcers impact on an individual's quality of life, and generate high costs to the overall health care system, further work is needed to explore alternative means of pressure ulcer treatment.

Read the detailed description

UVC or placebo UVC will be applied to wounds three times per week. Intact skin around the wound edge and the wound base will be irradiated.

02

Conditions studied

  • Pressure Ulcer

Keywords

  • skin
  • decubitus
  • pressure
  • sore
  • spinal cord injury
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 43 is above the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Toronto Rehabilitation Institute is the lead sponsor of 39 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • traumatic, non-traumatic or congenital spinal cord injury C2-L2
  • pressure ulcer stage 2 or higher

Exclusion criteria

Exclusion Criteria:

  • neoplastic wound
  • wound surgically repaired within past 3 months
  • wound currently treated with negative pressure therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
43 participants (actual)

Study arms

  • Experimental
    active UVC device

    Three times per week irradiation of wound base and periwound skin

    Device: ultraviolet therapy UV254

  • Placebo comparator
    Placebo UVC device

    Three times per week irradiation of wound base and periwound skin

    Device: Placebo ultraviolet therapy UV254

Interventions

  • Deviceultraviolet therapy UV254

    three times per week until wound closure or patient discharge from hospital

  • DevicePlacebo ultraviolet therapy UV254

    Three times per week irradiation of wound base and periwound skin

06

What researchers measure

Primary outcomes

  1. Change in ulcer area relative to baseline

    Wounds are photographed at baseline and measurement is repeated every week either until the wound is closed or the subject is discharged from hospital, up to a maximum of 32 weeks. A metric reference is fixed to skin adjacent to the wound. A blinded assessor measures area directly from the number-coded images using digital software. Percent change is calculated each week relative to baseline.

    Time frame: At baseline and repeated weekly up to wound closure or duration of hospital stay to a maximum of 32 weeks

Secondary outcomes

  1. Mean change in ulcer area between consecutive weeks

    Wounds are photographed at baseline and measurement is repeated every week either until the wound is closed or the subject is discharged from hospital, up to a maximum of 32 weeks. A metric reference is fixed to skin adjacent to the wound. A blinded assessor measures area directly from the number-coded images using digital software. Percent change in area relative to the previous measurement is calculated each week for the individual and then averaged for the individual over all weeks of the study.

    Time frame: At baseline and repeated weekly up to wound closure or duration of hospital stay up to a maximum of 32 weeks

  2. Change in Photographic Wound Assessment Tool (PWAT)

    The PWAT characterizes six aspects of wound appearance (wound edge, necrotic tissue type and amount, skin colour, granulation tissue and epithelialization), and yields scores ranging from 0-24, where higher scores indicate more severe wounds. A blinded assessor scored the PWAT using the number-coded images.

    Time frame: From baseline to wound closure or when the subject is discharged from hospital

  3. Change in Cardiff Wound Impact Schedule (CWIS)

    The CWIS is a condition-specific quality of life (QOL) tool that evaluates wound impact on four domains: overall QOL, well-being, physical experience and the perceived stress of the physical experience.

    Time frame: From baseline to wound closure or when subject is discharged from hospital

  4. Follow-up wound status

    Telephone interview - subjects were asked about status of study wounds - open or closed

    Time frame: At 1, 6 and 12 months post-intervention

07

Study locations

1 site
  • Toronto Rehabilitation Institute
    Toronto, Ontario M4G 3V9, Canada
08

References and documents

Publications

  • Nussbaum EL, Biemann I, Mustard B. Comparison of ultrasound/ultraviolet-C and laser for treatment of pressure ulcers in patients with spinal cord injury. Phys Ther. 1994 Sep;74(9):812-23; discussion 824-5. doi: 10.1093/ptj/74.9.812. PubMed 8066108 ↗
  • Nussbaum EL, Flett H, Hitzig SL, McGillivray C, Leber D, Morris H, Jing F. Ultraviolet-C irradiation in the management of pressure ulcers in people with spinal cord injury: a randomized, placebo-controlled trial. Arch Phys Med Rehabil. 2013 Apr;94(4):650-9. doi: 10.1016/j.apmr.2012.12.003. Epub 2012 Dec 13. PubMed 23246896 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01500174
Lead sponsor
Toronto Rehabilitation Institute
Collaborators
Ontario Neurotrauma Foundation
Responsible party
Ethne L Nussbaum (Principle Investigator, Toronto Rehabilitation Institute) — Principal investigator
First posted
Dec 28, 2011
Start date
Nov 2007
Primary completion
May 2010
Completion
May 2011
Last update
Sep 5, 2012

Study contacts

Ethne L Nussbaum, PhD
principal investigator · Toronto Rehabilitation Institute
Colleen F McGillivray, MD, FRCPC
principal investigator · Toronto Rehabilitation Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion